Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries-Reference-Cited by-同舟云学术

Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries

Published:2020-11-15 Issue:6 Volume:14 Page:685-698
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Banerjee Rupa¹^ORCID,Ali Raja Affendi Raja²^ORCID,Wei Shu Chen³^ORCID,Adsul Shashi⁴^ORCID

Affiliation:

1. IBD Center, Asian Institute of Gastroenterology, Hyderabad, India

2. Gastroenterology Unit, Department of Medicine, Faculty of Medicine, The National University of Malaysia, Kuala Lumpur, Malaysia

3. Department of Internal Medicine, IBD Clinical and Basic Research Integrated Center, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan

4. Takeda Pharmaceuticals International AG, Zurich, Switzerland

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2020/014/GNL014-06-03.pdf

Reference76 articles.

1. Inflammatory Bowel Disease

2. World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease

3. Epidemiology and risk factors for IBD

4. Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

5. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31

2. A Comparison of Clinical Outcomes of Colectomies for Pediatric and Adult Patients With Inflammatory Bowel Disease;The American Surgeon™;2024-06-03

3. Chemoprophylaxis of precancerous lesions in patients who are at a high risk of developing colorectal cancer (Review);Medicine International;2024-03-27

4. Exploring Impact of Probiotic‐Fermented Soymilk on Dextran‐Sulfate‐Sodium‐Induced Ulcerative Colitis via Modulating Inflammation and Gut Microbiota Profile;Molecular Nutrition & Food Research;2024-02

5. Treatment with antituberculosis agents after tuberculosis activation during ustekinumab treatment: Safety and effectiveness;Arab Journal of Gastroenterology;2024-02